Ascendis Pharma A/S
ASND
26 hedge funds and large institutions have $223M invested in Ascendis Pharma A/S in 2016 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
21% more capital invested
Capital invested by funds: $185M → $223M (+$38.4M)
17% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 6
4% more funds holding
Funds holding: 25 → 26 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$8.7M |
| 2 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$1.85M |
| 3 |
VAM
Visium Asset Management
New York
|
+$663K |
| 4 |
Morgan Stanley
New York
|
+$407K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$332K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Sio Capital Management
New York
|
-$1.73M |
| 2 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$567K |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$254K |
| 4 |
AA
ALPS Advisors
Denver,
Colorado
|
-$86K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$75.3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Citigroup
New York
| $1K | +$888 | +50 | New |
|
27
Citadel Advisors
Miami,
Florida
| – | -$21K | -1,156 | Closed |
|
ASND Hedge Fund Activity: Q1 2016 in Review
26 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Ascendis Pharma A/S (ASND) for Q1 2016, worth a combined $223M — up 21% from $185M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new ASND positions and 2 closed out — a net gain of 1 holder — while 7 added to existing stakes and 6 trimmed.
The largest buyer was RA Capital Management, adding an estimated $8.7M. The largest seller was Sio Capital Management, cutting an estimated $1.73M.
- 26 institutional investors held Ascendis Pharma A/S (ASND) as of Q1 2016, up from 25 in Q4 2015.
- Funds reported $223M of Ascendis Pharma A/S stock for Q1 2016, up 21% quarter-over-quarter.
- 3 funds opened new Ascendis Pharma A/S positions in Q1 2016 and 2 closed out, a net change of +1 holder.
- The largest Ascendis Pharma A/S buyer in Q1 2016 was RA Capital Management, an estimated $8.7M added.
- The largest Ascendis Pharma A/S seller in Q1 2016 was Sio Capital Management, an estimated $1.73M sold.
Based on aggregated 13F filings for Q1 2016.